Ultraviolet Therapy of Atopic Eczema

  • J. Krutman
  • M. Grewe
Conference paper

Abstract

Recent results from a pilot study have suggested that irradiation of patients with high doses of ultraviolet A1 radiation (UVA-1; 340–400 nm) may be effectively used as a monotherapy in the management of severe exacerbation of atopic dermatitis [1]. This assumption has recently been confirmed in a multicenter trial [2]. Accordingly, in this three-branched, randomized trial, atopic dermatitis patients were treated either with high-dose UVAi (10 days, 130 J/cm2/day; n = 20), or topically with fluocortolon (10 days, 1X daily; n = 17), or with conventional UVA-UVB therapy (10 days, 1 x daily, minimal effective dose-dependent; n = 16). By employing an established clinical scoring system, significant differences in favor of high-dose UVAi as well as fluocortolon therapy were observed (p<0.0001), as compared to UVA-UVB therapy. After 10 days, high-dose UVAi was found to be superior to fluocortolon (p<o.oo2). These clinical changes were reflected by concomitant changes in laboratory parameters. a sinificant reduction of elevated serum levels of eosinophilic cationic protein as well as of the blood eosinophil count was observed in patients undergoing high-dose UVA1 irradiation or fluocortolon treatment, but not UVA-UVB theraphy. These studies confirm the therapeutic effectiveness of high-dose UVA1 irradiation in the management of patients with atopic dermatis.

Keywords

Dermatitis Dermatol 

References

  1. 1.
    Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schöpf E: High-dose-UVAl therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 26: 225–230, 1992PubMedCrossRefGoogle Scholar
  2. 2.
    Krutmann J, Diepgen TL, Luger TA, Grabbe S, Meffert H, Soennichsen N, Czech W, Kapp A, Stege H, Grewe M, Schöpf E: High-dose-UVAl therapy for atopic dermatitis. J Invest Dermatol 104: 564, 1995Google Scholar
  3. 3.
    Grewe M, Gyufko K, Schöpf E, Krutmann J: Lesionai expression of interferon-y in atopic eczema. Lancet 343: 25–26, 1994PubMedCrossRefGoogle Scholar
  4. 4.
    Grewe M, Gyufko K, Krutmann J: Human keratinocytes produce interleukin-10: Modulation by ultraviolet B and ultraviolet Al radiation. J Invest Dermatol 104: 3–6, 1995PubMedCrossRefGoogle Scholar
  5. 5.
    Grewe M, Walter S, Gyufko K, Czech W, Schöpf E, Krutmann J: Analysis of the cytokine pattern expressed in-situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105: 407–410, 1995PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1997

Authors and Affiliations

  • J. Krutman
  • M. Grewe

There are no affiliations available

Personalised recommendations